Stocks and Investing
Stocks and Investing
Fri, December 29, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, December 28, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, December 27, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Ed Arce Reiterated (VERA) at Strong Buy and Held Target at $25 on, Dec 27th, 2023
Ed Arce of HC Wainwright & Co., Reiterated "Vera Therapeutics, Inc." (VERA) at Strong Buy and Held Target at $25 on, Dec 27th, 2023.
Ed has made no other calls on VERA in the last 4 months.
There are 3 other peers that have a rating on VERA. Out of the 3 peers that are also analyzing VERA, 0 agree with Ed's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Ed
- Steven Seedhouse of "Raymond James" Initiated at Buy and Held Target at $29 on, Monday, December 18th, 2023
- Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $22 on, Thursday, November 30th, 2023
- Farzin Haque of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $26 on, Friday, November 10th, 2023
Contributing Sources